Condition
Bacteraemia Caused by Gram-Negative Bacteria
Total Trials
2
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Fixed Long Antibiotic Course Of 14 Days
Research Leaders
5 sponsors active, led by Cantonal Hospital of St. Gallen
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Fixed Long Antibiotic Course Of 14 Days1
- Individualized Duration Of Antibiotic Therapy1
- Fixed Short Antibiotic Course Of 7 Days1
- Clinical Stabilitydriven Antibiotic Discontinuation Strategy1
- Standard Of Care Antibiotic Duration1
Active Sponsors
- Cantonal Hospital of St. Gallen1
- Ministry of Education, Universities and Research, Italy1
- University of Geneva, Switzerland1
- Centre Hospitalier Universitaire Vaudois1
- Valeria Cento1
Top Investigators
Humanitas University
University of Geneva, Switzerland
Related Conditions
- Febrile Neutropenia Fn1
- Bloodstream Infection1
- Gram Negative Infections1